AstraZeneca opened a new corporate office in Mumbai, in western India, on October 16, 2026, according to a stock exchange filing by AstraZeneca Pharma India, the company's India unit. Devendra Fadnavis, Chief Minister of the state of Maharashtra, inaugurated the 25,600-square-foot office. The office will house the company's commercial operations,...
AstraZeneca Brings Rare Disease Therapy to India
AstraZeneca India announced its entry into rare disease therapy in India. The company received regulatory approval for its ‘Selumetinib’ for patients in India. Globally, more than 400 million people are affected by rare diseases, and currently, there are 7,000 identified and recorded rare diseases. AstraZeneca has partnered the Organization of...
AstraZeneca’s Biliary Tract Cancer Drug Receives Regulatory Approval in India
British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca PLC's India arm announced that it received additional indication approval from the Central Drugs Standard Control Organization (CDSCO) for the drug Durvalumab to treat biliary tract cancer (BTC) in India. BTC is a group of rare and aggressive gastrointestinal cancers that form in the...